(Q50454508)

14 March 2018

title

Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG. (English)

1 reference

14 March 2018

0 references

8

1 reference

14 March 2018

author name string

Ece Erdağ

1

1 reference

14 March 2018

Ceren Şahin

2

1 reference

14 March 2018

Cem İsmail Küçükali

3

1 reference

14 March 2018

Sinem Bireller

4

1 reference

14 March 2018

Melike Küçükerden

5

1 reference

14 March 2018

Murat Kürtüncü

6

1 reference

14 March 2018

Recai Türkoğlu

7

1 reference

14 March 2018

Erdem Tüzün

9

1 reference

14 March 2018

Feyza Arıcıoğlu

10

1 reference

14 March 2018

publication date

21 February 2017

1 reference

14 March 2018

published in

Neurological Sciences

1 reference

14 March 2018

volume

38

1 reference

14 March 2018

issue

5

1 reference

14 March 2018

page(s)

833-843

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1007/s10072-017-2856-2

exact match

0 references

cites work

Pathogenesis of Behçet's disease: autoinflammatory features and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

21 January 2018

Neuro-Behçet syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Paraneoplastic anti-Hu serum: studies on human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

B cell-directed therapies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

B cells and antibodies in multiple sclerosis pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Humoral autoimmunity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Intravenous immunoglobulin therapy for resistant ocular Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-017-2856-2

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

21 January 2018

1 reference

12 December 2020

Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.

1 reference

12 December 2020

Silent neurological involvement in Behçet's disease.

1 reference

12 December 2020

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections

1 reference

12 December 2020

Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease

1 reference

12 December 2020

Anti-annexin V antibodies in neuro-Behçet patients: clinical significance and relation to disease activity

1 reference

12 December 2020

10.1007/S10072-017-2856-2

Identifiers

DOI

1 reference

14 March 2018

release_ucdkebi55ra4ngf6hvt75no3ru

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ucdkebi55ra4ngf6hvt75no3ru

24 November 2022

mapped directly with Wikidata item

PubMed ID

28224327

1 reference

14 March 2018